PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.25%
Positive revenue growth while 2127.T is negative. John Neff might see a notable competitive edge here.
6.66%
Positive gross profit growth while 2127.T is negative. John Neff would see a clear operational edge over the competitor.
45.88%
Positive EBIT growth while 2127.T is negative. John Neff might see a substantial edge in operational management.
51.13%
Positive operating income growth while 2127.T is negative. John Neff might view this as a competitive edge in operations.
46.91%
Positive net income growth while 2127.T is negative. John Neff might see a big relative performance advantage.
46.89%
Positive EPS growth while 2127.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
46.89%
Positive diluted EPS growth while 2127.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 2127.T is at 0.92%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
68.51%
10Y revenue/share CAGR under 50% of 2127.T's 965.41%. Michael Burry would suspect a lasting competitive disadvantage.
64.78%
5Y revenue/share CAGR at 50-75% of 2127.T's 126.84%. Martin Whitman would worry about a lagging mid-term growth trajectory.
35.69%
3Y revenue/share CAGR under 50% of 2127.T's 76.37%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
100.00%
10Y OCF/share CAGR in line with 2127.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
202.11%
Below 50% of 2127.T's 1976.61%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
95.22%
5Y net income/share CAGR similar to 2127.T's 95.77%. Walter Schloss might see both on parallel mid-term trajectories.
40.35%
Below 50% of 2127.T's 89.37%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
201.46%
Below 50% of 2127.T's 626.48%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
125.07%
5Y equity/share CAGR at 50-75% of 2127.T's 172.12%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
58.34%
Below 50% of 2127.T's 125.60%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.90%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-6.06%
Inventory is declining while 2127.T stands at 0.81%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.11%
Asset growth above 1.5x 2127.T's 0.47%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.35%
BV/share growth above 1.5x 2127.T's 1.60%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.77%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.60%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.